"BR2019-05" OR "PD19-02" OR "PD19-01" OR "BR2018-15" OR "BR2018-13" OR "BR2018-04" OR "PD18-01" OR "GC17-06" OR "BR2017-05" OR "BR2017-15" OR "GC16-30" OR "BR2016-04" OR "PD15-06" OR "BR2015-02" OR "GC14-55" OR "BR2014-12" OR "BR2014-04" OR "BR2014-03" OR "BR2014-02" OR "GC12-72" found 6 records

6 records – page 1 of 1.

CMA submission to the study of Bill C-37

1 document

BR2017-05.pdf

Tamper Resistance under the Controlled Drugs and Substances Act

1 document

BR2015-02.pdf

Proposed amendments to the marihuana for medical purposes regulations

1 document

BR2014-12.pdf

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

1 document

BR2014-04.pdf

Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations

1 document

BR2014-03.pdf

Non-prescription availability of low-dose codeine products

1 document

BR2018-04.pdf

6 records – page 1 of 1.

Results

CMA submission to the study of Bill C-37

Tamper Resistance under the Controlled Drugs and Substances Act

Proposed amendments to the marihuana for medical purposes regulations

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations

Non-prescription availability of low-dose codeine products